Cargando…
Biomarkers for type 2 diabetes
BACKGROUND: The prevalence and incidence of type 2 diabetes (T2D), representing >90% of all cases of diabetes, are increasing rapidly worldwide. Identification of individuals at high risk of developing diabetes is of great importance as early interventions might delay or even prevent full-blown d...
Autor principal: | Laakso, Markku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768493/ https://www.ncbi.nlm.nih.gov/pubmed/31500825 http://dx.doi.org/10.1016/j.molmet.2019.06.016 |
Ejemplares similares
-
Cardiovascular Disease in Type 2 Diabetes From Population to Man to Mechanisms: The Kelly West Award Lecture 2008
por: Laakso, Markku
Publicado: (2010) -
The “Common Soil Hypothesis” Revisited—Risk Factors for Type 2 Diabetes and Cardiovascular Disease
por: Fernandes Silva, Lilian, et al.
Publicado: (2021) -
Genetic Screening for the Risk of Type 2 Diabetes: Worthless or valuable?
por: Lyssenko, Valeriya, et al.
Publicado: (2013) -
Genetics of Type 2 Diabetes: Past, Present, and Future
por: Laakso, Markku, et al.
Publicado: (2022) -
Statins and risk of type 2 diabetes: mechanism and clinical implications
por: Laakso, Markku, et al.
Publicado: (2023)